These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3120466)

  • 21. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
    Adeyemo T; Ojewunmi O; Oyetunji A
    Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of hemoglobinopathies in Egypt.
    El-Beshlawy A; Youssry I
    Hemoglobin; 2009; 33 Suppl 1():S14-20. PubMed ID: 20001619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 95% of women in England not screened for sickle cell anaemia or thalassaemia by 10 week target.
    Mayor S
    BMJ; 2008 Mar; 336(7642):468. PubMed ID: 18309986
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain.
    Modell B; Petrou M; Ward RH; Fairweather DV; Rodeck C; Varnavides LA; White JM
    Lancet; 1984 Dec; 2(8416):1383-6. PubMed ID: 6150377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta+-Thalassaemia, Haemoglobin S and Hereditary elliptocytosis in a Zairian Family. Ischaemic costal necroses in a child with sickle cell beta+-Thalassaemia.
    Ros G; Seynhaeve V; Fiasse L
    Acta Haematol; 1976; 56(4):241-52. PubMed ID: 826082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antenatal screening for couples at risk of having children with sickle cell disorders.
    Eboh W; Van den Akker O
    Midwives (1995); 1997 Feb; 110(1309):26-7. PubMed ID: 9128568
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of thalassaemia in Cyprus.
    Angastiniotis MA; Hadjiminas MG
    Lancet; 1981 Feb; 1(8216):369-71. PubMed ID: 6109998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for sickle cell disease and thalassaemia saving lives.
    Kmietowicz Z
    BMJ; 2004 Jul; 329(7457):69. PubMed ID: 15242893
    [No Abstract]   [Full Text] [Related]  

  • 29. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premarital screening of beta-thalassemia trait in the province of Denizli, Turkey.
    Keskin A; Türk T; Polat A; Koyuncu H; Saracoglu B
    Acta Haematol; 2000; 104(1):31-3. PubMed ID: 11111119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sickle cell and thalassaemia screening: early care.
    Anglin S
    Pract Midwife; 2007 Oct; 10(9):22-5. PubMed ID: 17990690
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial of a special issue. Current status of therapeutics and preventive measures for patients with thalassaemia and sickle cell disease.
    Reddy PH
    Cardiovasc Hematol Agents Med Chem; 2012 Mar; 10(1):2. PubMed ID: 22239494
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of thalassemia.
    Loukopoulos D; Kaltsoya-Tassiopoulou A; Fessas P
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1419-27. PubMed ID: 6316486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for detection of beta-thalassemia trait for sickle cell screening programs.
    Honig GR; Hoversten GH
    Am J Med Technol; 1974 Dec; 40(12):523-8. PubMed ID: 4440708
    [No Abstract]   [Full Text] [Related]  

  • 35. Experience of a sickle cell screening program in Baltimore.
    Miller JM; Davis DC
    J Natl Med Assoc; 1979 Sep; 71(9):839-41. PubMed ID: 501751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of deletional alpha-thalassaemia with sickle cell beta-thalassaemia and its influence on foetal haemoglobin expression.
    Vidaud-Raphanaud D; Krishnamoorthy R; Schaison G; Labie D
    Ann Genet; 1988; 31(1):32-5. PubMed ID: 2451466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid detection of fetal Mendelian disorders: thalassemia and sickle cell syndromes.
    Traeger-Synodinos J; Vrettou C; Kanavakis E
    Methods Mol Biol; 2008; 444():133-45. PubMed ID: 18425477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal screening and genetic counseling for sickle cell trait.
    Grossman LK; Holtzman NA; Charney E; Schwartz AD
    Am J Dis Child; 1985 Mar; 139(3):241-4. PubMed ID: 3976605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic counseling in sickle cell anemia: experiences with couples at risk.
    Neal-Cooper F; Scott RB
    Public Health Rep; 1988; 103(2):174-8. PubMed ID: 3128834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalassaemia in Malaysia: a strategy for prevention.
    Ainoon O; Cheong SK
    Malays J Pathol; 1994 Jun; 16(1):23-7. PubMed ID: 16329572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.